share_log
Reuters ·  05/08 07:07

Syndax Pharmaceuticals Inc - Has Sufficient Cash Runway to Fund Its Research, Clinical Development and Commercial Operations Through 2026

Syndax Pharmicals Inc-在2026年之前有足够的现金流为其研究、临床开发和商业运营提供资金

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发